Stryker Board Member Sold $117.78M In Company Stock - Stryker (NYSE:SYK)

Wendy's (WEN) +5% on private equity interest; Equifax (EFX) +6.4% after dividend declaration; Jack Henry (JKHY) +7.4% on earnings beat; PulteGroup (PHM) +4.6% on analyst rating; Stryker (SYK) +2.7% on $100M contract.

Stryker (SYK) shares rose 2.7% after its Stryker Sales unit secured a $100M contract modification from the US Defense Logistics Agency. The stock closed at $340.05, up 2.6% from the previous close. The company reported a 9.4% year-on-year revenue increase to $6.59B in Q2 but missed organic sales growth expectations.

Wolfe Research downgraded Stryker (SYK) to Peer Perform, citing a difficult second-half outlook after a March cyber disruption and noting the June quarter did not fully catch up. Wolfe said Stryker’s guidance implies 54% of revenue in 2H. Wolfe upgraded Abbott (ABT) to Outperform with a $130 target, citing better 2027 catalysts.

Stryker (NYSE:SYK) reported Q2 results on July 30 with sales up 9.4% to $6.6B and EPS up 44.1% to $3.30. The company cited recovery from a prior cyber incident. It guided full-year organic net sales growth of 8.3% to 9.3% and adjusted EPS of $14.95 to $15.10, while the article highlights a large gap between reported and adjusted earnings.

Stryker (SYK) reported Q2 2026 adjusted EPS of $3.69, up 17.9% year over year, with organic net sales up 9% and adjusted gross margin at 66%. Management cited recovery from a prior cybersecurity incident and higher production. Full-year organic net sales guidance is 8.3% to 9.3%, and adjusted EPS guidance is $14.95 to $15.10.

Stryker (SYK) shares fell about 7.3% in the morning after the company reported Q2 results. Revenue rose 9.4% year over year to $6.59 billion, but organic growth of about 9% met only Wall Street expectations and missed forecasts. Adjusted earnings were $3.69 per share, beating estimates by 5.8%, and guidance was slightly raised.